Immune, Developmental, and Synaptic Pathways Define Bipolar Disorder Clinical Heterogeneity

Area of Science:

• Psychiatric Genetics
• Genomics
• Neuroscience

Background:

• Clinical heterogeneity in bipolar disorder (BD) complicates diagnosis and treatment.
• A genetic approach is crucial for understanding BD's underlying biology.
• Previous genetic studies lacked the resolution to address BD's complexity.

Purpose of the Study:

• To investigate the hypothesis that distinct BD subphenotypes are associated with different common variant genetic architectures.
• To identify genetically-informed dimensions of BD heterogeneity.

Main Methods:

• Genome-wide association study (GWAS) of up to 23,819 BD cases and 163,839 controls.
• Integration of GWAS results with external summary statistics for BD and schizophrenia (SCZ) using Multi-Trait Analysis of GWAS (MTAG).
• Analysis of SNP-heritability, genetic correlations, genomic loci, and functional/pathway analyses.

Main Results:

• Four genetically-informed dimensions of BD were identified: Severe Illness, Core Mania, Externalizing/Impulsive Comorbidity, and Internalizing/Affective Comorbidity.
• Up to 181 subphenotype-associated loci were identified, with 53 being novel.
• The Severe Illness dimension showed a unique neuro-immune signature (HLA-DMB), and the Internalizing/Affective dimension was linked to neurodevelopmental genes (DCC).

Conclusions:

• Bipolar disorder's clinical heterogeneity is underpinned by a complex, multi-layered genetic architecture.
• The findings provide an empirical framework to advance psychiatric nosology and inform personalized interventions.
• This research supports a transition towards precision psychiatry by delineating biologically-grounded dimensions of BD.